Catalyst Wire Dossier Catalyst Wire Dossier

Ultradian Subcutaneous Hydrocortisone Infusion

hydrocortisone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ultradian Subcutaneous Hydrocortisone Infusion, covering 2024-06-07 to 2024-06-07. Get the full timeline:

Most recent: Clinical Trial Update: Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia [Phase 1, Phase 2]

See pricing